Authors

• María Inmaculada Domínguez‐Mozo (ORCID: https://orcid.org/0000-0001-9236-5717)
• Jaime Masjuán (ORCID: https://orcid.org/0000-0003-1329-0943)
• Juan Luis Chico‐García (ORCID: https://orcid.org/0000-0001-6557-912X)
• Roberto Álvarez‐Lafuente (ORCID: https://orcid.org/0000-0002-3132-1486)
• Xavier Montalbán (ORCID: https://orcid.org/0000-0002-0098-9918)
• Susana Sainz de la Maza
• Enric Monreal (ORCID: https://orcid.org/0000-0003-3293-0125)
• María Luisa Martínez Ginés
• José Ignacio Fernández-Velasco (ORCID: https://orcid.org/0000-0001-9148-671X)
• Alexander Rodero-Romero (ORCID: https://orcid.org/0009-0004-3816-2715)
• Maria Ángel García‐Martínez (ORCID: https://orcid.org/0000-0001-9487-2747)
• Raquel Sainz-Amo
• Noelia Villarrubia (ORCID: https://orcid.org/0000-0002-2114-8632)
• Fernando Rodríguez‐Jorge (ORCID: https://orcid.org/0000-0002-4567-0177)
• Lucienne Costa‐Frossard (ORCID: https://orcid.org/0000-0002-6512-4413)
• Haydee Goicochea Briceño
• Luisa María Villar (ORCID: https://orcid.org/0000-0002-9067-3668)
• José Manuel García‐Domínguez (ORCID: https://orcid.org/0000-0002-5205-3652)
• José Luís Veiga-González

Institutions

• Hospital General Universitario Gregorio Marañón (ES)
• Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
• Spanish Multiple Sclerosis Network (ES)
• Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES)
• Vall d'Hebron Institut de Recerca (ES)
• Instituto Ramón y Cajal de Investigación Sanitaria (ES)

Publication Details

Journal

Frontiers in Immunology

Published

2025-12-05

DOI

https://doi.org/10.3389/fimmu.2025.1729500

Primary Topic

Multiple Sclerosis Research Studies

Type

article

Field-Weighted Citation Impact

0.00

Funders

• European Commission
• Instituto de Salud Carlos III